Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zymeworks Inc (ZYME)

Zymeworks Inc (ZYME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 802,223
  • Shares Outstanding, K 69,577
  • Annual Sales, $ 76,300 K
  • Annual Income, $ -122,700 K
  • EBIT $ -125 M
  • EBITDA $ -114 M
  • 60-Month Beta 1.24
  • Price/Sales 10.26
  • Price/Cash Flow N/A
  • Price/Book 2.49

Options Overview Details

View History
  • Implied Volatility 162.31% ( +16.41%)
  • Historical Volatility 64.75%
  • IV Percentile 98%
  • IV Rank 83.83%
  • IV High 188.44% on 04/10/25
  • IV Low 26.89% on 09/11/24
  • Put/Call Vol Ratio 1.05
  • Today's Volume 45
  • Volume Avg (30-Day) 98
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 5,913
  • Open Int (30-Day) 5,292

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.50
  • Number of Estimates 6
  • High Estimate -0.40
  • Low Estimate -0.58
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -92.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.69 +7.86%
on 04/16/25
13.23 -12.85%
on 05/02/25
+0.59 (+5.39%)
since 04/15/25
3-Month
9.03 +27.69%
on 04/10/25
15.25 -24.39%
on 02/18/25
-3.48 (-23.18%)
since 02/14/25
52-Week
8.21 +40.44%
on 06/26/24
17.70 -34.86%
on 11/12/24
+2.38 (+26.01%)
since 05/15/24

Most Recent Stories

More News

Business Summary

Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 12.38
2nd Resistance Point 11.97
1st Resistance Point 11.75
Last Price 11.53
1st Support Level 11.12
2nd Support Level 10.71
3rd Support Level 10.49

See More

52-Week High 17.70
Fibonacci 61.8% 14.07
Fibonacci 50% 12.95
Fibonacci 38.2% 11.84
Last Price 11.53
52-Week Low 8.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar